Medication Adherence in Patients with Hematologic Malignancies who are Hematopoietic Stem Cell Transplantation Survivors: A Qualitative Study
CONCLUSION: Facilitators and barriers to medication adherence can be physical, psychological, organizational, or social. Further, there are many aspects of the medication regimens that significantly increase patient distress. Hence, supportive interventions to improve medication adherence in patients undergoing HSCT may need to incorporate strategies to manage medication side-effects and skills to improve psychological well-being and social support.PMID:37516379 | DOI:10.1016/j.jtct.2023.07.019
Source: Cancer Control - Category: Cancer & Oncology Authors: Hermioni L Amonoo Emma C Deary Annie Wang Richard A Newcomb Elizabeth Daskalakis Daniel Weber Katherine E Holmbeck Joanna J Choe Anisa Nabily Corey Cutler Lara N Traeger Areej El-Jawahri Source Type: research
More News: Cancer | Cancer & Oncology | Health Insurance | Hematology | Insurance | Psychology | Stem Cell Therapy | Stem Cells | Study | Transplants